Pharmacokinetics of bendroflumethiazide alone and in combination with propranolol and hydralazine
- 1 January 1982
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 21 (4), 315-323
- https://doi.org/10.1007/bf00637620
Abstract
Bendroflumethiazide (Bft) was administered to 6 healthy subjects at 3 different dose levels (2.5, 5 and 10 mg) in a cross-over design, either as capsules (2.5 mg) or as tablets (5 mg). Its pharmacokinetics were evaluated then and following administration of a fixed combination of Bft with propranolol and hydralazine to a further 7 volunteers. Plasma and urinary concentrations of Bft were determined by a new fluorimetric — thin-layer chromotography procedure. Peak plasma levels occurred after 2–3 h and averaged 15, 27 and 45 µg/l in the three dose groups. Areas under the plasma concentration — time curves (AUC0→12), which were 75, 147 and 250 µg l−1 h respectively, and cumulative urinary recovery (20%) were independent of the dose administered and the type of formulation. Thus Bft kinetics proved to be linear within the dose range evaluated. The plasma clearance was calculated to be 505 ml/min, renal clearance 108 ml/min and nonrenal clearance 396 ml/min. Bioavailability of Bft was not altered following administration of the fixed combination. The amount of propranolol found in the circulation did not change, whereas that of hydralazine (determined as apparent hydralazine) increased by 59% when the fixed combination was administered.Keywords
This publication has 21 references indexed in Scilit:
- A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.British Journal of Clinical Pharmacology, 1979
- Beta‐adrenoceptor blocking drugs and diuretics in hypertension.British Journal of Clinical Pharmacology, 1979
- Effect of Food on the Bioavailability of BendroflumethiazideActa Medica Scandinavica, 1978
- Pharmacokinetics of bendroflumethiazide in hypertensive patientsEuropean Journal of Clinical Pharmacology, 1978
- Fluorimetrische bestimmung von propranolol und seines metaboliten n-desisopropylpropranolol in plasma und urin durch direkte auswertung von dünnschichtchromatogrammenJournal of Chromatography B: Biomedical Sciences and Applications, 1977
- Pharmacological Basis for Combination Therapy of HypertensionAnnual Review of Pharmacology and Toxicology, 1977
- Interpretation of Plasma Concentration-Time Curves after Oral DosingJournal of Pharmaceutical Sciences, 1977
- A GLC assay for bendroflumethiazide. Preliminary data about its plasma level in manEuropean Journal of Clinical Pharmacology, 1976
- Studies on hydralazineEuropean Journal of Clinical Pharmacology, 1976
- The determination of hydralazine in plasma by gas-liquid chromatographyJournal of Chromatography A, 1975